Article Versions Notes

Cheng M-H, Weng J-Y, Chuang C-H, Liao W-T, Lai Y-F, Liu J-Y, Fang Y-P. Prolonging the Half-Life of Histone Deacetylase Inhibitor Belinostat via 50 nm Scale Liposomal Subcutaneous Delivery System for Peripheral T-Cell Lymphoma. Cancers. 2020; 12(9):2558. https://doi.org/10.3390/cancers12092558

Cheng, Meng-Hsuan, Jun-Yi Weng, Chih-Hung Chuang, Wei-Ting Liao, Yu-Fong Lai, Jia-Yu Liu, and Yi-Ping Fang. 2020. "Prolonging the Half-Life of Histone Deacetylase Inhibitor Belinostat via 50 nm Scale Liposomal Subcutaneous Delivery System for Peripheral T-Cell Lymphoma" Cancers 12, no. 9: 2558. https://doi.org/10.3390/cancers12092558

Cheng, M. -H., Weng, J. -Y., Chuang, C. -H., Liao, W. -T., Lai, Y. -F., Liu, J. -Y., & Fang, Y. -P. (2020). Prolonging the Half-Life of Histone Deacetylase Inhibitor Belinostat via 50 nm Scale Liposomal Subcutaneous Delivery System for Peripheral T-Cell Lymphoma. Cancers, 12(9), 2558. https://doi.org/10.3390/cancers12092558